Aldosterone actions on distal tubule

RAAS Cascade - The Pressure Regulator

• Trigger: ↓ Renal blood flow / ↓ Na⁺ delivery to distal tubule.
• Goal: ↑ Blood pressure & restore renal perfusion.

⭐ Exam Favorite: Angiotensin Converting Enzyme (ACE) not only creates Angiotensin II but also breaks down bradykinin, a vasodilator. This dual action is key to understanding ACE inhibitor side effects like dry cough and angioedema.

Principal & Intercalated Cells - Aldosterone's Workshop

Aldosterone fine-tunes electrolyte and acid-base balance by acting on two key cell types in the late distal tubule and collecting duct.

• Principal Cells: Salt & Water Balance

  • Upregulates luminal Epithelial Na+ Channels (ENaC) → ↑Na+ reabsorption.
  • Upregulates luminal Renal Outer Medullary K+ (ROMK) channels → ↑K+ secretion.
  • Increases basolateral Na+/K+-ATPase activity to drive the gradients.
  • Net Effect: Retains Na+ (and water follows), excretes K+.

• α-Intercalated Cells: Acid Secretion

  • Stimulates H+-ATPase activity → ↑H+ secretion into the lumen.
  • Contributes to acidifying the urine.

⭐ Hyperaldosteronism can lead to metabolic alkalosis due to increased H+ secretion by α-intercalated cells.

Clinical Correlates - Hyper vs. Hypo

• Hyperaldosteronism (e.g., Conn's Syndrome)

  • Causes: Adrenal adenoma or bilateral adrenal hyperplasia.
  • Labs: ↑ Aldosterone, ↓ Renin, Hypokalemia, Metabolic Alkalosis.
  • Clinical: Hypertension, muscle weakness, paresthesias. No significant edema or hypernatremia due to aldosterone escape.

• Hypoaldosteronism

  • Causes: Adrenal insufficiency (Addison's), ACE inhibitors, ARBs, Spironolactone, Type 4 RTA.
  • Labs: ↓ Aldosterone, Hyperkalemia, Metabolic Acidosis (non-anion gap).
  • Clinical: Hypotension, arrhythmias (from ↑ K+).

⭐ Exam Favorite: ACE inhibitors are a common cause of iatrogenic hypoaldosteronism. They block Angiotensin II formation, thus decreasing aldosterone secretion and potentially leading to life-threatening hyperkalemia.

Pharmacology - Taming Aldosterone

• Mineralocorticoid Receptor Antagonists (MRAs): Competitively block aldosterone receptors in principal cells.
  • Spironolactone: Non-selective; also blocks androgen receptors (→ gynecomastia, impotence).
  • Eplerenone: Selective for mineralocorticoid receptors; fewer side effects.
• ENaC Blockers: Inhibit the Epithelial Sodium Channel (ENaC) directly.
  • Amiloride
  • Triamterene
• Overall Effect: All are potassium-sparing diuretics.
  • Result in ↓Na⁺ reabsorption and ↓K⁺ secretion.
  • Used for hypertension, heart failure, and hyperaldosteronism.

⭐ Hyperkalemia is a life-threatening side effect, especially when combined with ACE inhibitors, ARBs, or NSAIDs.

High-Yield Points - ⚡ Biggest Takeaways

• Aldosterone primarily acts on principal cells and α-intercalated cells in the distal tubule and collecting duct.
• It increases Na+ reabsorption by upregulating apical ENaC channels and the basolateral Na+/K+ ATPase in principal cells.
• This leads to increased K+ secretion through apical ROMK channels (hypokalemia).
• It also stimulates H+ secretion from α-intercalated cells, contributing to metabolic alkalosis.
• Net effect: ↑ blood volume/pressure, ↓ serum K+, and metabolic alkalosis.
• Blocked by spironolactone and eplerenone.